Roche stops diabetes drug trial after safety issues

July 10, 2013 6:06 AM

11 0

Roche stops diabetes drug trial after safety issues

"Roche is working with investigators to support the management of patients and their transition from aleglitazar treatment to other blood sugar control therapies," Roche's chief medical offer and head of product development Hal Barron said in a statement on Wednesday.

Patients in a late-stage trial of the drug suffered side effects affecting organs such as their kidneys and hearts, a spokesman for the Basel-based drugmaker said.

Also read: Gambia's Jammeh in shock election loss after 22-year rule

Read more

To category page

Loading...